Catalyst Wire Dossier Catalyst Wire Dossier

Fluticasone propionate and salmeterol inhalation powder

· Actavis Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fluticasone propionate and salmeterol inhalation powder, covering 2021-09-24 to 2021-09-24. Get the full timeline:

Most recent: Clinical Trial Update: Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma [Phase 3]

See pricing